Valuation: Vivos Therapeutics, Inc.

Market Cap 4.5M 3.89M 3.64M 3.34M 6.27M 428M 6.37M 42.67M 16.75M 215M 16.91M 16.54M 710M P/E 2026 *
-0.23x
P/E 2027 * -0.41x
Enterprise Value 4.5M 3.89M 3.64M 3.34M 6.27M 428M 6.37M 42.67M 16.75M 215M 16.91M 16.54M 710M EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.13x
Free-Float
73.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.62%
1 week-20.98%
Current month-20.98%
1 month-32.36%
3 months-51.18%
6 months-79.10%
Current year-84.04%
1 week 0.3
Extreme 0.3019
0.54
1 month 0.3
Extreme 0.3019
0.54
Current year 0.3
Extreme 0.3019
2.69
1 year 0.3
Extreme 0.3019
5.12
3 years 0.3
Extreme 0.3019
48.79
5 years 0.3
Extreme 0.3019
177.25
10 years 0.3
Extreme 0.3019
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 01/09/2016
Chief Executive Officer 68 01/09/2016
Director TitleAgeSince
Chairman 68 01/06/2020
Director/Board Member 87 01/06/2020
Director/Board Member 59 01/06/2020
Date Insider Type Main position Quantity % Market Cap.
30/06/26
Seneca Partners, Inc.
BuyCompany 2,749,330 19.7870%
30/06/26
Seneca Partners, Inc.
OtherCompany 2,749,330 19.7870%
04/02/26 Other

Director

3,997 0.0424%
Change 5-day change 1-year change 3-year change Capi.($)
+0.62%-20.98%-92.83%-95.03% 4.5M
-0.06%+1.08%+34.86%+28.50% 12.79B
-0.29%-0.17%+21.63%+22.61% 6.81B
+0.79%+2.67%+57.15%+28.07% 6.21B
+6.41%+8.59% - - 5.5B
-0.58%-8.31%-25.19%+34.98% 4.36B
+1.30%-2.64%-22.77%-18.05% 4.04B
+4.46%+10.44%+42.40%-39.12% 1.91B
-0.51%-5.18%-15.07%+200.51% 1.75B
+3.67%+6.92%+68.57%+0.78% 1.71B
Average +1.58%-0.51%+7.64%+18.14% 4.51B
Weighted average by Cap. +1.20%+1.40%+23.17%+26.52%

Financials

2026 *2027 *
Net sales 24.06M 20.81M 19.43M 17.83M 33.53M 2.29B 34.06M 228M 89.48M 1.15B 90.33M 88.36M 3.79B 34.09M 29.49M 27.54M 25.26M 47.51M 3.24B 48.27M 323M 127M 1.63B 128M 125M 5.38B
Net income -23.82M -20.6M -19.24M -17.65M -33.19M -2.27B -33.72M -226M -88.59M -1.14B -89.43M -87.48M -3.76B -13.78M -11.92M -11.13M -10.21M -19.21M -1.31B -19.52M -131M -51.28M -658M -51.76M -50.63M -2.17B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
270
Date Price Change Volume
07/08/26 $0.3240 +0.62% 1,323,356
06/08/26 $0.3220 -5.46% 1,309,932
05/08/26 $0.3406 -26.31% 7,626,357
04/08/26 $0.4622 +9.89% 35,483,275
03/08/26 $0.4206 +2.59% 110,978
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.3240USD
Average target price
2.117USD
Spread / Average Target
+553.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock